Study Design:
Literature review.
Objective:
To provide an overview of the recent advances in spinal oncology, emphasizing the key
role of the surgeon in the treatment of patients with spinal metastatic tumors.
Methods:
Literature review.
Results:
Therapeutic advances led to longer survival times among cancer patients, placing
significant emphasis on durable local control, optimization of quality of life, and
daily function for patients with spinal metastatic tumors. Recent integration of modern
diagnostic tools, precision oncologic treatment, and widespread use of new technologies
has transformed the treatment of spinal metastases. Currently, multidisciplinary spinal
oncology teams include spinal surgeons, radiation and medical oncologists, pain and
rehabilitation specialists, and interventional radiologists. Consistent use of common
language facilitates communication, definition of treatment indications and outcomes,
alongside comparative clinical research. The main parameters used to characterize
patients with spinal metastases include functional status and health-related quality of
life, the spinal instability neoplastic score, the epidural spinal cord compression
scale, tumor histology, and genomic profile.
Conclusions:
Stereotactic body radiotherapy revolutionized spinal oncology through delivery of
durable local tumor control regardless of tumor histology. Currently, the major surgical
indications include mechanical instability and high-grade spinal cord compression, when
applicable, with surgery providing notable improvement in the quality of life and
functional status for appropriately selected patients. Surgical trends include less
invasive surgery with emphasis on durable local control and spinal stabilization.